HIV Integrase Inhibitors
- Name
- HIV Integrase Inhibitors
- Accession Number
- DBCAT001873
- Description
Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA.
- Drugs
Drug Drug Description Raltegravir An antiretroviral agent used for the treatment of HIV infections in conjunction with other antiretrovirals. Dolutegravir An antiviral agent used for the treatment of HIV-1 infections in combination with other antiretroviral agents. Elvitegravir An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. HIV Integrase Inhibitor HIV Integrase Inhibitor is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects). Cabotegravir An HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. - Drugs & Drug Targets